BHP's Copper-Led Surge Lifts Market Cap by A$19.4 Billion
Earnings James Calloway

BHP's Copper-Led Surge Lifts Market Cap by A$19.4 Billion

BHP's copper-focused results lifted its market value by A$19.4 billion, but shares now trade above analyst targets, suggesting limited upside.

BHP
Archer Aviation Gains Fade as Boeing Deal Boost Diminishes
Markets Daniel Marsh

Archer Aviation Gains Fade as Boeing Deal Boost Diminishes

Archer Aviation (ACHR) shares rose 3.45% Friday but fell 4.83% for the week. The Boeing deal's boost has nearly evaporated, with shares just 0.64% above pre-announcement levels.

ACHR BA
RFAI Soars 356% Post Nanyang Approval, Redemption Risk Looms
Markets Daniel Marsh

RFAI Soars 356% Post Nanyang Approval, Redemption Risk Looms

RFAI shares rocketed 356% after the Nanyang deal vote passed, but redemptions may drain trust cash, leaving the SPAC's future uncertain.

RFAI
Boston Scientific Rebounds 2% but Faces Headwinds as Week Closes Lower
Markets Daniel Marsh

Boston Scientific Rebounds 2% but Faces Headwinds as Week Closes Lower

Boston Scientific (BSX) climbed 2.03% to $50.37 on Friday, recovering 38% of Thursday's sharp decline. The stock still ended the week down 2.82% amid concerns over product demand and competition.

BSX PEN
SELLAS Surges 15% as Investors Bet Big on AML Trial Results
Analysis Daniel Marsh

SELLAS Surges 15% as Investors Bet Big on AML Trial Results

SELLAS shares climbed 15.37% to $15.46, lifting market cap to $3.12B. Cash covers only 4.4%, with pipeline value hinging on AML trial results.

SLS
Werewolf Therapeutics Stock Doubles on Ambros Merger; Legacy Holders Get 6.8%
IPO Michael Okonkwo

Werewolf Therapeutics Stock Doubles on Ambros Merger; Legacy Holders Get 6.8%

Werewolf Therapeutics shares doubled after announcing a merger with Ambros Therapeutics. Existing shareholders will hold only 6.8% of the combined entity, with a $150 million PIPE funding the lead drug program.

HOWL
Rivian Stock Hits Analyst Target as R1 Incentives Test Pricing Power
Markets Daniel Marsh

Rivian Stock Hits Analyst Target as R1 Incentives Test Pricing Power

Rivian shares jumped 6% to $16.96, reaching the average analyst target. New R1 incentives could accelerate Q3 deliveries but may pressure pricing and margins.

RIVN TSLA LCID
Hut 8 Drops 10% as AI Execution Risks Trump Bitcoin Rally
Markets Daniel Marsh

Hut 8 Drops 10% as AI Execution Risks Trump Bitcoin Rally

Hut 8 shares slid 10% despite Bitcoin's 6% gain, as investors price in AI construction risks. The market cap implies 5.6x projected NOI.

HUT APLD IREN
USA Rare Earth Soars 13% on Policy Bets, But Valuation Questions Loom
Markets Daniel Marsh

USA Rare Earth Soars 13% on Policy Bets, But Valuation Questions Loom

USAR shares surged 13% on Friday, driven by rare-earth supply policy concerns, but the company's valuation remains stretched at ~360x trailing revenue.

USAR
Ford Stock Rebounds 3.4% on Light Volume, Erasing Most of Thursday's Drop
Markets Daniel Marsh

Ford Stock Rebounds 3.4% on Light Volume, Erasing Most of Thursday's Drop

Ford shares rebounded 3.4% to $14.47, recovering 94% of Thursday's decline, but trading volume was light, signaling a broad-market move rather than a shift in investor sentiment.

F
Royal Caribbean Reassigns Ships to Asia, Trims 2027 Sailings
Markets Daniel Marsh

Royal Caribbean Reassigns Ships to Asia, Trims 2027 Sailings

Royal Caribbean (RCL) cancels two 2027 sailings, reallocating 77,668 berth-days to Asia-Pacific. Capacity remains steady; shares up 1.13%.

RCL
Infleqtion Jumps 10% as Analysts Back Cash-Rich Quantum Push
Analysis Daniel Marsh

Infleqtion Jumps 10% as Analysts Back Cash-Rich Quantum Push

Infleqtion shares surged 9.8% to $13.79 after Citi raised its target, while analysts highlight a $582M cash cushion for quantum expansion.